Kenvue Inc. (KVUE)

The base outcome assumes steady consumer replenishment in non-discretionary over-the-counter healthcare categories, maintaining predictable top-line progression and stable operating margins. Steady channel execution preserves shelf placement across mass retail partners while cash generation covers regular dividends and scheduled debt maturities. This modal path projects a target of $18.17 with an estimated probability of 55.0%, delivering an implied return of 5.6% against $17.20 (as of 2026-10-02).

• Stable revenue growth driven by steady consumer replenishment in essential health categories
• Operating margins normalizing gradually with post-separation supply chain efficiencies
• Steady retail shelf space allocation with primary distribution partners
• Modest capital expenditure supporting disciplined debt service and dividend continuity